Oncolytic virus-based suicide gene therapy for cancer treatment: a perspective of the clinical trials conducted at henry ford health

HIGHLIGHTS

• who: Shivani Thoidingjam from the Seoul National University Bundang Hospital have published the article: Oncolytic virus-based suicide gene therapy for cancer treatment: a perspective of the clinical trials conducted at Henry Ford Health, in the Journal: (JOURNAL) of January/14,/2015
• what: This systematic review provides an overview of approaches and products employed for treating patients including the products developed at Henry Ford Health. This trial, designed to evaluate the safety and tolerability of oncolytic adenovirus in humans for prostate cancer therapy, builds on the pioneering studies at Henry Ford Health in the late . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.